Dynamic changes of Apo A1 mediated by LXR/RXR/ABCA1 pathway in brains of the aging rats with cerebral hypoperfusion

Brain Research Bulletin

Volumn 100, Issue , 2014, Pages 84-92

  Wang, Linhui ^a   Zhang, Xiong ^a   Lü, Yang ^b   Tian, Mingyuan ^a   Li, Yu ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

ABCA1; Apolipoprotein A1; Liver X receptor ; Retinoic X receptor ; Vascular dementia

Indexed keywords

ABC TRANSPORTER A1; APOLIPOPROTEIN A1; BETA ACTIN; BRAIN PROTEIN; HIGH DENSITY LIPOPROTEIN; LIVER X RECEPTOR BETA; RETINOID X RECEPTOR ALPHA;

AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN BLOOD FLOW; BRAIN PERFUSION; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL METABOLISM; COMMON CAROTID ARTERY; CONTROLLED STUDY; HOMEOSTASIS; LIPOPROTEIN BLOOD LEVEL; MALE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

2 VESSEL OCCLUSION; 2VO; ABCA1; AD; ALZHEIMER'S DISEASE; APOLIPOPROTEIN A1; ATP-BINDING CASSETTE TRANSPORTER A1; BBB; BLOOD-BRAIN BARRIER; HDL; HIGH-DENSITY LIPOPROTEIN; LIVER X RECEPTOR; LIVER X RECEPTOR-Β; LXR; RETINOIC X RECEPTOR-Α; RETINOID X RECEPTOR; RXR; VASCULAR DEMENTIA; VD;

AGING; ANIMALS; APOLIPOPROTEIN A-I; ATP BINDING CASSETTE TRANSPORTER 1; BLOTTING, WESTERN; BRAIN; CHOLESTEROL, HDL; DEMENTIA, VASCULAR; DISEASE MODELS, ANIMAL; FLUORESCENT ANTIBODY TECHNIQUE; MALE; ORPHAN NUCLEAR RECEPTORS; RATS; RATS, SPRAGUE-DAWLEY; RETINOID X RECEPTORS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

EID: 84890810467     PISSN: 03619230     EISSN: 18732747     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2013.11.004     Document Type: Article

References (27)

1. Bjorkhem I., Meaney S. Brain cholesterol: long secret life behind a barrier. Arterioscler. Thromb. Vasc. Biol. 2004, 24:806-815.
2. Buono C., Li Y., Waldo S.W., et al. Liver X receptors inhibit human monocyte-derived macrophage foam cell formation by inhibiting fluid-phase pinocytosis of LDL. J. Lipid Res. 2007, 48(11):2411.
3. Cheng O., Ostrowski R.P., Liu W., Zhang J.H. Activation of liver X receptor reduces global ischemia injury by reduction of nuclear factor-kappaB. Neuroscience 2010, 166(4):1101-1109.
4. Crisafulli C., Di Paola R., Mazzon E., Paterniti I., Galuppo M., Genovese T., et al. Liver X receptor agonist treatment reduced splanchnic ischemia and reperfusion injury. J. Leukoc. Biol. 2010, 87(2):309-321.
5. Elali A., Hermann D.M. Liver X receptor activation enhances blood-brain barrier integrity in the ischemic brain and increases the abundance of ATP-binding cassette transporters ABCB1 and ABCC1 on brain capillary cells. Brain Pathol. 2011, 22(2):175-187.
6. Fan J., Donkin J., Wellington C. Greasing the wheels of Aβ clearance in Alzheimer's disease: the role of lipids and apolipoprotein E. Biofactors 2009, 35(3):239-248.
7. Farkas E., Luiten P.G., Bari F. Permanent, bilateral common carotid artery occlusion in the rat: a model for chronic cerebral hypoperfusion-related neurodegenerative diseases. Brain Res. Rev. 2007, 54(1):162-180.
8. Feingold K.R., Jiang Y.J. The mechanisms by which lipids coordinately regulate the formation of the protein and lipid domains of the stratum corneum: role of fatty acids, oxysterols, cholesterol sulfate and ceramides as signaling molecules. Dermatoendocrinology 2011, 3(2):113-118.
9. Francis G.A., Fayard E., Picard F., Auwerx J. Nuclear receptors and the control of metabolism. Annu. Rev. Physiol. 2003, 65:261-311.
10. Hartmann T., Kuchenbecker J., Grimm M.O. Alzheimer's disease: the lipid connection. J. Neurochem. 2007, 103(Suppl. 1):159-170.
11. Hozoji-Inada M., Munehira Y., Nagao K., et al. Liver X receptor beta (LXRbeta) interacts directly with ATP-binding cassette A1 (ABCA1) to promote high density lipoprotein formation during acute cholesterol accumulation. J. Biol. Chem. 2011, 286(22):20117-20124.
12. Jiang X.C., Goldberg I.J., Park T.S. Sphingolipids and cardiovascular diseases: lipoprotein metabolism, atherosclerosis and cardiomyopathy. Adv. Exp. Med. Biol. 2011, 721:19-39.
13. Joyce C., Freeman L., Brewer H.B., Santamarina-Fojo S. Study of ABCA1 function in transgenic mice. Arterioscler. Thromb. Vasc. Biol. 2003, 23(6):965-971.
14. Kalaria R.N., Maestre G.E., Arizaga R., et al. Alzheimer's disease and vascular dementia in developing countries: prevalence, management, and risk factors. Lancet Neurol. 2008, 7(9):812-826.
15. Karasinska J.M., Rinninger F., Lutjohann D., Ruddle P., Franciosi S., Kruit J.K., et al. Specific loss of brain ABCA1 increases brain cholesterol uptake and influences neuronal structure and function. J. Neurosci. 2009, 29(11):3579-3589.
16. Kivipelto M., Ngandu T., Fratiglioni L., et al. Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease. Arch. Neurol. 2005, 62(10):1556-1560.
17. Koldamova R., Lefterov I. Role of LXR and ABCA1 in the pathogenesis of Alzheimer's disease - implications for a new therapeutic approach. Curr. Alzheimer Res. 2007, 4(2):171-178.
18. Michel V., Bakovic M. Lipid rafts in health and disease. Biol. Cell 2007, 99:129-140.
19. Morales J.R., Ballesteros I., Deniz J.M., et al. Activation of liver X receptors promotes neuroprotection and reduces brain inflammation in experimental stroke. Circulation 2008, 118(14):1450-1459.
20. Puca A.A., Chatgilialoglu C., Ferreri C. Lipid metabolism and diet: possible mechanisms of slow aging. Int. J. Biochem. Cell Biol. 2008, 40(3):324-333.
21. Raffaitin C., Gin H., Empana J.P., et al. Metabolic syndrome and risk for incident Alzheimer's disease or vascular dementia. Diabetes Care 2009, 32(1):169.
22. Russell D.W. The enzymes, regulation, and genetics of bile acid synthesis. Annu. Rev. Biochem. 2003, 72:137-174.
23. Sironi L., Mitro N., Cimino M., et al. Treatment with LXR agonists after focal cerebral ischemia prevents brain damage. FEBS Lett. 2008, 582(23-24):3396-3400.
24. Tontonoz P., Mangelsdorf D.J. Liver X receptor signaling pathways in cardiovascular disease. Mol. Endocrinol. 2003, 17(6):985.
25. Yokoyama S. Assembly of high-density lipoprotein. Arterioscler. Thromb. Vasc Biol. 2006, 26(1):20-27.
26. Yoshikawa T., Murase K., Oku N., et al. Quantification of the heterogeneity of cerebral blood flow in vascular dementia. J. Neurol. 2003, 250(2):194-200.
27. Zelcer N., Khanlou N., Clare R., et al. Attenuation of neuroinflammation and Alzheimer's disease pathology by liver X receptors. Proc. Natl. Acad. Sci. U.S.A. 2007, 104(25):10601-10606.